SILO PHARMA, INC. Proceeds from Issuance of Warrants
SILO PHARMA, INC. (SILO) reported Proceeds from Issuance of Warrants of $3.73 million for the 12-month period ending 2025-12-31, per its POS AM filed 2026-04-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-04-14
- SILO PHARMA, INC. proceeds from issuance of warrants for the quarter ending 2025-12-31 was $2.13M.
- SILO PHARMA, INC. proceeds from issuance of warrants for the quarter ending 2025-09-30 was $0.00.
- SILO PHARMA, INC. proceeds from issuance of warrants for the quarter ending 2024-12-31 was $0.00.
- SILO PHARMA, INC. proceeds from issuance of warrants for the quarter ending 2024-09-30 was $0.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 9 month as first filed | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2.13M derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $2.13M derived: sum of 2 quarters · filed 2026-04-14 | $3.73M POS AM · filed 2026-04-14 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.59M 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | $1.59M 10-Q · filed 2025-08-13 | |||||
| 2024-12-31 | $0.00 derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $0.00 derived: sum of 2 quarters · filed 2026-04-14 | $1.67M POS AM · filed 2026-04-14 | $1.74M 10-K · filed 2025-03-28 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.67M 10-Q · filed 2025-11-13 | $1.74M 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $1.67M 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |